Cargando…
Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s
Antibody responses to variant surface antigens (VSAs) produced by the malaria parasite Plasmodium falciparum may contribute to age-related natural immunity to severe malaria. One VSA family, P. falciparum erythrocyte membrane protein-1 (PfEMP1), includes a subset of proteins that binds endothelial p...
Autores principales: | Tewey, Madison A., Coulibaly, Drissa, Lawton, Jonathan G., Stucke, Emily M., Zhou, Albert E., Berry, Andrea A., Bailey, Jason A., Pike, Andrew, Dara, Antoine, Ouattara, Amed, Lyke, Kirsten E., Ifeonu, Olukemi, Laurens, Matthew B., Adams, Matthew, Takala-Harrison, Shannon, Niangaly, Amadou, Kouriba, Bourema, Koné, Abdoulaye K., Rowe, J. Alexandra, Doumbo, Ogobara K., Patel, Jigar J., Tan, John C., Felgner, Philip L., Plowe, Christopher V., Thera, Mahamadou A., Travassos, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597466/ https://www.ncbi.nlm.nih.gov/pubmed/37791774 http://dx.doi.org/10.1128/msphere.00451-23 |
Ejemplares similares
-
Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation
por: Ventimiglia, Noah T., et al.
Publicado: (2021) -
Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag
por: Stucke, Emily M., et al.
Publicado: (2019) -
Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023) -
Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles
por: Tebben, Kieran, et al.
Publicado: (2023) -
Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)